CN115337344B - Traditional Chinese medicine composition and medicine for treating cervical vision disorder and preparation method thereof - Google Patents
Traditional Chinese medicine composition and medicine for treating cervical vision disorder and preparation method thereof Download PDFInfo
- Publication number
- CN115337344B CN115337344B CN202210891726.3A CN202210891726A CN115337344B CN 115337344 B CN115337344 B CN 115337344B CN 202210891726 A CN202210891726 A CN 202210891726A CN 115337344 B CN115337344 B CN 115337344B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- cervical
- vision disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cervical vision disorder, a medicine and a preparation method thereof, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine raw materials of the traditional Chinese medicine composition for treating the cervical spondylosis type vision disorder comprise astragalus membranaceus, radix sileris, cassia twig, radix puerariae, lycopodium clavatum, radix salviae miltiorrhizae, ligusticum chuanxiong, wild chrysanthemum flower, peppermint, folium mori, cortex fraxini, glauber salt, cortex phellodendri, honeysuckle, angelica sinensis, safflower and liquorice, and the traditional Chinese medicine raw materials interact with each other, so that the cervical spondylosis type vision disorder mainly comprising blurred vision, compound vision, strabismus, eye socket or eyeball swelling, pain, photophobia, lacrimation, eyelid sagging, nystagmus and even sudden blindness, which appears after the cervical spondylosis, intervertebral disc or soft tissue injury caused by various reasons, can be treated at the same time, clinical practice proves that the cervical spondylosis type vision disorder has obvious clinical effect, the cure rate is up to more than 95%, the relapse is not easy to occur after the cure, and the treatment course is short, and the cervical spondylosis type vision disorder can be cured for 1-2 months.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating cervical vision disorder, a medicine and a preparation method thereof.
Background
The cervical vision disorder clinically refers to symptoms mainly comprising blurred vision, double vision, strabismus, eye socket or eyeball part distension, pain, photophobia, lacrimation, eyelid sagging, nystagmus, even sudden blindness and the like which occur after cervical vertebral body, intervertebral disc or soft tissue injury caused by various reasons. In the past, the treatment of vision disorder is mainly focused on organic lesions of eyes, but the relationship between vision and cervical spondylosis is often neglected, so that certain eye diseases are not healed.
For the etiology of cervical vision disorder, modern medicine mostly affects cervical nerves, transmitters, blood supply of blood vessels, internal and external muscles of the eye and the like from cervical vertebra diseases, and sudden cervical trauma or long-time strain and other factors lead to internal and external unbalance of cervical vertebra, such as: the physiological curvature of cervical vertebra changes, vertebral bodies are subjected to rotation displacement or bone spur, uncinate joint and other facet joint disorder, intervertebral disc protrusion and the like to stimulate or press sympathetic nerves near the vertebral bodies, and most obvious is that the sympathetic nerves are influenced, so that the eye movement nerves cause visual disturbance such as upper eyelid sagging, vision decline and the like caused by the eye external muscle dysfunction. In addition, since postganglionic fibers from the upper cervical sympathogenic segment are distributed in the eye and carotid plexus, imbalance between the inside and outside of the cervical vertebrae can also lead to ocular circulation and mydriasis, and eyelid muscle disorders, which can lead to ocular vision discomfort. In addition, zhang Changjiang and the like consider that vertebral artery insufficiency is a major cause of visual center or brain damage in the study of brain visual center blood supply; the "Ling Shu-Da Huo Lun" states that "the essence of the five zang-organs and six fu-organs is the essence of the eyes. However, most patients and doctors fail to think about the correlation between cervical spondylosis and vision disorder, and finally the patients cannot cure for a long time, so that the preparation of a medicament and a method for effectively treating cervical-derived vision disorder has important practical significance.
Disclosure of Invention
Aiming at the problems of the background technology, the invention aims to provide a traditional Chinese medicine composition for treating cervical dystonia, which has obvious curative effect on cervical dystonia, has short curative effect, high cure rate and no toxic or side effect, and has the functions of tonifying qi, nourishing blood, promoting blood circulation, relieving pain, dredging collaterals and improving eyesight.
The invention further aims to provide a medicament for treating cervical dystonia, which can effectively treat cervical dystonia, has a high curative effect and is not easy to relapse after healing.
The invention also aims to provide a preparation method of the medicament for treating the cervical vision disorder, which is simple, can conveniently prepare the medicament for treating the cervical vision disorder and is used for treating the cervical vision disorder.
To achieve the purpose, the invention adopts the following technical scheme:
a traditional Chinese medicine composition for treating cervical vision disorder, which consists of the following traditional Chinese medicine raw materials: astragalus root, ledebouriella root, cassia twig, kudzuvine root, common clubmoss herb, danshen root, szechuan lovage rhizome, wild chrysanthemum flower, peppermint, mulberry leaf, ash bark, glauber salt, amur corktree bark, honeysuckle flower, chinese angelica, safflower and liquoric root.
Further, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 20-25 parts of astragalus membranaceus, 20-25 parts of radix saposhnikoviae, 20-25 parts of cassia twig, 20-25 parts of radix puerariae, 20-25 parts of lycopodium clavatum, 20-25 parts of radix salviae miltiorrhizae, 20-25 parts of ligusticum wallichii, 20-25 parts of wild chrysanthemum flower, 20-25 parts of peppermint, 10-15 parts of mulberry leaf, 10-15 parts of ash bark, 20-25 parts of glauber salt, 20-25 parts of cortex phellodendri, 20-25 parts of honeysuckle, 20-25 parts of angelica sinensis, 20-25 parts of safflower and 10-15 parts of liquorice.
In one technical scheme of the invention, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 20 parts of glauber salt, 20 parts of amur corktree bark, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 10 parts of liquorice.
In another technical scheme of the invention, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 25 parts of lycopodium clavatum, 25 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 25 parts of glauber salt, 20 parts of amur corktree bark, 20 parts of honeysuckle, 25 parts of Chinese angelica, 25 parts of safflower and 10 parts of liquorice.
In another technical scheme of the invention, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 20 parts of astragalus, 25 parts of divaricate saposhnikovia root, 25 parts of cassia twig, 20 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 20 parts of szechuan lovage rhizome, 20 parts of wild chrysanthemum flower, 20 parts of peppermint, 10 parts of mulberry leaf, 15 parts of ash bark, 20 parts of glauber salt, 25 parts of phellodendron, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 15 parts of liquorice.
The preparation method of the medicine for treating cervical vision disorder, which uses the traditional Chinese medicine composition for treating cervical vision disorder, comprises the following steps: weighing the raw materials according to the parts by weight, uniformly mixing the raw materials, grinding or decocting the raw materials with water, and preparing into an oral preparation to obtain the medicine for treating cervical dyskinesia.
The medicament for treating the cervical vision disorder is prepared by the preparation method of the medicament for treating the cervical vision disorder.
Further, the medicament for treating the cervical vision disorder is an oral preparation.
Further, the oral preparation is any one of decoction, pill, powder, granule, oral liquid, capsule and tablet.
The technical scheme has the following beneficial effects: the traditional Chinese medicine raw materials of the traditional Chinese medicine composition for treating the cervical spondylosis type vision disorder comprise astragalus membranaceus, radix sileris, cassia twig, radix puerariae, lycopodium clavatum, radix salviae miltiorrhizae, rhizoma ligustici chuanxiong, wild chrysanthemum flower, peppermint, folium mori, cortex fraxini, glauber salt, cortex phellodendri, honeysuckle, angelica sinensis, safflower and liquorice, and the traditional Chinese medicine raw materials interact with each other, so that the cervical spondylosis type vision disorder mainly comprising symptoms of blurred vision, compound vision, strabismus, eye socket or eye-ball swelling, pain, photophobia, lacrimation, eyelid sagging, nystagmus, even sudden blindness and the like can be treated after the cervical spondylosis, the curative ratio reaches more than 95%, the relapse is not easy to occur after the recovery, and the treatment course is short and the cervical spondylosis type vision disorder can be recovered after the recovery for 1-2 months.
Detailed Description
The technical scheme of the invention is further described below with reference to the specific embodiments.
A traditional Chinese medicine composition for treating cervical vision disorder comprises the following traditional Chinese medicine raw materials: astragalus root, ledebouriella root, cassia twig, kudzuvine root, common clubmoss herb, danshen root, szechuan lovage rhizome, wild chrysanthemum flower, peppermint, mulberry leaf, ash bark, glauber salt, amur corktree bark, honeysuckle flower, chinese angelica, safflower and liquoric root.
At present, most patients and doctors fail to think about the relevance of cervical spondylosis and vision disorder and finally cause the patients to be unhealed after long-term treatment for the vision disorder treatment of most organic lesions of eyes, so that the preparation of a medicament and a method for effectively treating cervical vision disorder have important practical significance.
The traditional Chinese medicine composition for treating cervical spondylosis is prepared from astragalus membranaceus, radix sileris, cassia twig, kudzuvine root, lycopodium clavatum, radix salviae miltiorrhizae, ligusticum chuanxiong, wild chrysanthemum flower, peppermint, mulberry leaf, ash bark, glauber salt, cortex phellodendri, honeysuckle, angelica sinensis, safflower and liquorice through interaction of the above medicinal materials, and has the advantages of treating cervical spondylosis, intervertebral disc or soft tissue injury caused by various reasons, treating cervical spondylosis with symptoms such as blurred vision, compound vision, strabismus, eye socket or eye bulge, pain, photophobia, eyelid sagging, nystagmus and even sudden blindness, and the like, treating both symptoms and root causes of cervical spondylosis through clinical practice, ensuring that the cervical spondylosis is obviously clinically effective, the cure rate is more than 95%, the cure is not easy to recur after the cure, and the treatment course is short, and the traditional Chinese medicine composition for treating cervical spondylosis can be cured for 1-2 months.
It is worth to say that the traditional Chinese medicine composition for treating cervical dystonia is applied to the medicines for treating cervical dystonia.
Further illustrates that the traditional Chinese medicine composition for treating cervical dyskinesia consists of the following traditional Chinese medicine raw materials in parts by weight: 20-25 parts of astragalus membranaceus, 20-25 parts of radix saposhnikoviae, 20-25 parts of cassia twig, 20-25 parts of radix puerariae, 20-25 parts of lycopodium clavatum, 20-25 parts of radix salviae miltiorrhizae, 20-25 parts of ligusticum wallichii, 20-25 parts of wild chrysanthemum flower, 20-25 parts of peppermint, 10-15 parts of mulberry leaf, 10-15 parts of ash bark, 20-25 parts of glauber salt, 20-25 parts of cortex phellodendri, 20-25 parts of honeysuckle, 20-25 parts of angelica sinensis, 20-25 parts of safflower and 10-15 parts of liquorice.
It is worth to say that, the cause of cervical vision disorder is the vertebral artery blood supply deficiency caused by cervical disease, which is the main cause of vision center or brain damage, the cause and pathogenesis of traditional Chinese medicine is "qi and blood deficiency, blood stasis and eye obstruction", the proposed treatment is "qi-tonifying blood, blood circulation promoting and pain relieving, vein relaxing and eyesight improving", when the medicine is administered, if the patient is biased to the symptoms of qi and blood deficiency obviously, the mass fraction of astragalus root, cassia twig, angelica, safflower, red sage root, szechuan lovage rhizome and the like can be increased properly; for obvious symptoms of blood stasis, the mass parts of the radix sileris, the radix puerariae, the lycopodium clavatum, the phellodendron amurense and the like can be properly increased; the weight portions of wild chrysanthemum, honeysuckle, peppermint, mulberry leaf, ash bark, glauber salt and the like can be properly increased for the obvious vision blurring symptoms.
The pharmacological effects of the traditional Chinese medicine composition for treating cervical dyskinesia are as follows:
the astragalus has the effects of tonifying qi and yang, tonifying the sanitation and strengthening the surface, inducing diuresis and relieving edema, promoting the production of body fluid and nourishing blood, promoting the circulation of qi and relieving arthralgia, and the astragalus water decoction, polysaccharide and saponin have the effects of protecting and promoting the hematopoietic function, and the astragalus polysaccharide can promote the synthesis of RNA and protein, so that cells grow vigorously. Ramulus Cinnamomi has effects of warming and dredging channels, dispelling cold and relieving pain, so it can be used for treating syndrome of congealing cold and blood stagnation, and ramulus Cinnamomi oil can dilate blood vessel, improve blood circulation, and promote blood flow to body surface. Chuan Xiong is good at moving, and its nature is ascending and dispersing, so that it can "go upward to head and eyes", it can promote blood circulation, promote qi, dispel wind and alleviate pain, dang Gui is sweet and pungent in taste, both good and good in blood-replenishing, and "Cheng Zhong Yao" is a qi-flowing medicine in blood and a holy medicine in blood, safflower and Dan Shen have the effects of promoting blood circulation, dredging channels, dispelling blood stasis and relieving pain, ligustrazine, dang Gui and sodium ferulate thereof, safflower yellow and liposoluble tanshinone substance can dilate blood vessels, reduce vascular resistance, remarkably increase blood flow, inhibit platelet aggregation and improve microcirculation. The compatibility of astragalus root, cassia twig, ligusticum wallichii, chinese angelica and safflower can effectively improve the vascular condition of eyes and neck. Radix sileris, pungent and warm in flavor and smell, has the effects of dispelling wind and cold, eliminating dampness and relieving pain, and is a wind-damp-dispelling and arthralgia-relieving herb. The lycopodium clavatum powder, bitter and dry, warm and general, can dispel wind-damp, enter liver and particularly dredge meridian, and the lycopodium clavatum alcohol extract has obvious analgesic effect, and can be used for treating wind-cold-dampness arthralgia, joint ache and difficulty in flexion and extension. Pueraria is pungent in flavor, can activate meridians and collaterals, can directly dilate blood vessels, reduces peripheral resistance, has obvious blood pressure reducing effect, and can better relieve the 'tight neck' symptoms of patients with hypertension, so that the cervical hyperbaric pain is treated clinically. The wild chrysanthemum flower has the characteristics of bitter taste in the liver, clearing and purging liver fire, pungent and cold taste, dispelling wind-heat, and treating eye diseases such as conjunctival congestion and swelling and pain due to wind-heat upward attack, the volatile oil has strong inflammatory effect on chemical inflammatory factors, and the water extract has good inflammatory effect on inflammatory factors caused by heterologous proteins. The mulberry leaf can dispel wind-heat, bitter and cold enter liver to clear liver heat, and Gan Runyi yin is used for improving eyesight, and is used for treating conjunctival congestion, pain and excessive tears caused by wind-heat up attack and liver fire up-flaming, the honeysuckle flower is sweet and cold in quality and light in weight, aromatic and transparent, the phellodendron bark has the effects of clearing heat and drying dampness, purging fire and detoxifying, and the compatibility of the medicines such as the mulberry leaf, the honeysuckle flower, the mint and the phellodendron bark can enhance the effects of clearing head and eyes and relieving sore throat. Qin Pi and Xuan Ming Bai are indicated for eye diseases such as conjunctival congestion, swelling and pain, and nebula membrane.
In one technical scheme of the invention, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 20 parts of glauber salt, 20 parts of amur corktree bark, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 10 parts of liquorice.
In another technical scheme of the invention, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 25 parts of lycopodium clavatum, 25 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 25 parts of glauber salt, 20 parts of amur corktree bark, 20 parts of honeysuckle, 25 parts of Chinese angelica, 25 parts of safflower and 10 parts of liquorice.
In still another technical scheme of the invention, the traditional Chinese medicine composition for treating cervical vision disorder consists of the following traditional Chinese medicine raw materials in parts by weight: 20 parts of astragalus, 25 parts of divaricate saposhnikovia root, 25 parts of cassia twig, 20 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 20 parts of szechuan lovage rhizome, 20 parts of wild chrysanthemum flower, 20 parts of peppermint, 10 parts of mulberry leaf, 15 parts of ash bark, 20 parts of glauber salt, 25 parts of phellodendron, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 15 parts of liquorice.
The preparation method of the medicine for treating cervical vision disorder comprises the following steps of: weighing the raw materials according to the parts by weight, uniformly mixing the raw materials, grinding or decocting the raw materials with water, and preparing into an oral preparation to obtain the medicine for treating cervical dyskinesia.
The preparation method of the medicine for treating cervical vision disorder in the technical scheme is simple and low in cost, and the medicine can be prepared according to the conventional method in the field.
The medicament for treating the cervical vision disorder is prepared by the preparation method of the medicament for treating the cervical vision disorder.
The medicine for treating the cervical vision disorder prepared by the preparation method has the advantages of short treatment course, high curative effect and difficult recurrence after healing, has the functions of tonifying qi and nourishing blood, activating blood and relieving pain, and dredging collaterals and improving eyesight, and has obvious curative effect on the cervical vision disorder.
Further described, the medicament for treating cervical vision disorder is an oral preparation.
Further described, the oral preparation is any one of decoction, pill, powder, granule, oral liquid, capsule and tablet.
Specifically, the medicine for treating cervical vision disorder in the technical scheme is prepared into any conventional oral preparation by adopting a conventional method of a traditional Chinese medicine preparation, for example, all raw materials of the traditional Chinese medicine composition can be ground into powder, and the powder is prepared into powder for oral administration after uniform mixing; the raw materials can be decocted together with water and concentrated into decoction for administration, and meanwhile, the concentrated decoction after decoction can be concentrated into paste, and auxiliary materials and the like can be added to prepare conventional oral preparations such as pills, granules, tablets, capsules, oral liquid and the like.
The administration method comprises the following steps: taking oral decoction as an example, the oral decoction can be taken for 2 times per day (1 time in the morning and evening each day), 150-200 ml per time and can be healed for 1-2 months.
The technical scheme of the invention is further described below in conjunction with specific embodiments.
Example 1
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 20 parts of glauber salt, 20 parts of amur corktree bark, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 10 parts of liquorice.
Example 2
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 25 parts of lycopodium clavatum, 25 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 25 parts of glauber salt, 20 parts of amur corktree bark, 20 parts of honeysuckle, 25 parts of Chinese angelica, 25 parts of safflower and 10 parts of liquorice.
Example 3
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 20 parts of astragalus, 25 parts of divaricate saposhnikovia root, 25 parts of cassia twig, 20 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 20 parts of szechuan lovage rhizome, 20 parts of wild chrysanthemum flower, 20 parts of peppermint, 10 parts of mulberry leaf, 15 parts of ash bark, 20 parts of glauber salt, 25 parts of phellodendron, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 15 parts of liquorice.
Example 4
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 25 parts of astragalus, 23 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 23 parts of kudzuvine root, 20 parts of common clubmoss herb, 20 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 20 parts of peppermint, 12 parts of mulberry leaf, 10 parts of ash bark, 20 parts of glauber salt, 20 parts of amur corktree bark, 25 parts of honeysuckle, 24 parts of Chinese angelica, 20 parts of safflower and 10 parts of liquorice.
Example 5
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 20 parts of astragalus, 20 parts of divaricate saposhnikovia root, 21 parts of cassia twig, 24 parts of kudzuvine root, 20 parts of lycopodium clavatum, 22 parts of red sage root, 23 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 14 parts of ash bark, 25 parts of glauber salt, 20 parts of amur corktree bark, 23 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 12 parts of liquorice.
Example 6
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 23 parts of astragalus membranaceus, 25 parts of divaricate saposhnikovia root, 24 parts of cassia twig, 20 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 20 parts of ligusticum wallichii, 20 parts of wild chrysanthemum flower, 20 parts of peppermint, 10 parts of mulberry leaf, 15 parts of ash bark, 24 parts of glauber salt, 25 parts of phellodendron, 25 parts of honeysuckle, 20 parts of Chinese angelica, 22 parts of safflower and 15 parts of liquorice.
Example 7
The traditional Chinese medicine composition for treating the cervical-source visual disorder comprises the following traditional Chinese medicine raw materials in parts by weight (1 part refers to 1 gram): 25 parts of astragalus, 24 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 22 parts of kudzuvine root, 25 parts of lycopodium clavatum, 25 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 11 parts of ash bark, 25 parts of glauber salt, 24 parts of amur corktree bark, 20 parts of honeysuckle, 23 parts of Chinese angelica, 25 parts of safflower and 10 parts of liquorice.
Example 8
A medicine (decoction) for treating cervical vision disorder is prepared from the traditional Chinese medicine composition of example 1, and the preparation method is as follows: the raw materials according to the composition of example 1 are prepared, each raw material is decocted with water twice for 2 hours each time, the water added in each decoction is 3-5 cm after soaking the medicine surface, and the two decoctions are combined after the decoction is completed, so that the obtained decoction is the medicine for treating cervical vision disorder.
The administration method comprises the following steps: the decoction is divided into 2 parts, and is taken 1 time each in the morning and evening.
The clinical effect of the traditional Chinese medicine composition for treating cervical vision disorder
The applicant applied the traditional Chinese medicine composition for treating cervical vision disorder provided in examples 1 to 7 to clinic, and treated 88 patients with cervical vision disorder, 46 women, 42 men, and 30-65 years old with a disease course of half a year to 20 years, on average 4.2 years.
Wherein, the patients with light symptoms, the patients with light eye symptoms, the patients with light cervical vertebra and arm movement are slightly limited, and the patients are cured after taking the medicine for 2 to 3 weeks. The eye symptoms of a part of severe patients are obvious, the neck pain is uncomfortable, the dizziness and headache are occasionally caused, the cervical vertebra and arm hand movements are obviously limited, the eye symptoms are obviously relieved after taking the medicine for 1 month, the neck pain is relieved, the clinical symptoms basically disappear after taking the medicine for 2 months, in 88 cases, the eye symptoms of 84 cases of patients can be obviously improved or healed after taking the medicine, the cure rate reaches more than 95%, the clinical application of the traditional Chinese medicine composition of the technical scheme is carried out for many years, the patient does not have any adverse reaction after taking the medicine, the treatment course is short, the curative effect is obvious, the cure rate is high, and if the traditional Chinese medicine composition of the technical scheme is popularized in clinic, the great social benefit and economic benefit can be obtained. The effects of the present invention are further described below in conjunction with three typical cases.
Typical case 1
Somebody else, 44 years old, 9 months 11 days of 2019.
The main complaints are progressive decline of vision, eye dryness for more than half a year, and cervical spondylosis history. The vision is reduced progressively, eyes are dry and hard, the eyes are bitter in mouth, the neck is lightly pressed and painful, and the cervical vertebra movement is slightly limited under no obvious cause before half a year. The clinic visit in 2019, 9 and 11 days indicates that the physiological curvature of the cervical vertebra is straightened, the traditional Chinese medicine composition is administered for two months after being prepared into decoction, the vision is better, the symptoms of dry eyes disappear, no recurrence is seen in two months, and the follow-up visit is not performed until now.
Typical case 2
A man, 39 years old, 6 months and 6 days in 2020.
The eye is distended, painful, photophobia and lacrimation, neck pain discomfort, dizziness and headache, dry stool, and has a cervical spondylosis history after 2-3 days. In the ophthalmic treatment, the organic pathological changes of the eyes are not indicated, and the cervical vertebra X-ray sheet indicates that the intervertebral space is narrowed. Western medicine treatment can temporarily relieve but frequently recurs. The decoction prepared by taking the traditional Chinese medicine composition for treating cervical vision disorder has the advantages that symptoms such as eye distension, pain, photophobia and lacrimation are obviously relieved after being taken for 1 month, neck pain is relieved, and clinical symptoms are basically disappeared after being taken for 2 months.
Typical case 3
A man, 51 years old, 12 months and 7 days in 2020.
Complaints of blurred vision, nystagmus for more than one month, cervical spondylosis history, neck tenderness, mild limitation of cervical vertebra movement and occasional numbness of the upper limbs. No eye organic lesions are indicated in the previous ophthalmic visit in month 12 of 2020, cervical vertebra X-ray films are indicated before 1 year, cervical vertebra lip changes before and after cervical vertebra and uncinate joint hyperplasia are indicated. The decoction prepared by taking the traditional Chinese medicine composition for treating cervical vision disorder in 12 months and 7 days is obviously reduced in 1 month vision blur and nystagmus after taking the prescription for 2 months, and clinical symptoms are basically disappeared.
The technical principle of the present invention is described above in connection with the specific embodiments. The description is made for the purpose of illustrating the general principles of the invention and should not be taken in any way as limiting the scope of the invention. Other embodiments of the invention will be apparent to those skilled in the art from consideration of this specification without undue burden.
Claims (8)
1. The traditional Chinese medicine composition for treating the cervical vision disorder is characterized by comprising the following traditional Chinese medicine raw materials in parts by weight: 20-25 parts of astragalus membranaceus, 20-25 parts of radix saposhnikoviae, 20-25 parts of cassia twig, 20-25 parts of radix puerariae, 20-25 parts of lycopodium clavatum, 20-25 parts of radix salviae miltiorrhizae, 20-25 parts of ligusticum wallichii, 20-25 parts of wild chrysanthemum flower, 20-25 parts of peppermint, 10-15 parts of mulberry leaf, 10-15 parts of cortex fraxini, 20-25 parts of glauber salt, 20-25 parts of cortex phellodendri, 20-25 parts of honeysuckle, 20-25 parts of angelica sinensis, 20-25 parts of safflower and 10-15 parts of liquorice.
2. The traditional Chinese medicine composition for treating cervical-derived vision disorder according to claim 1, wherein the traditional Chinese medicine composition for treating cervical-derived vision disorder is composed of the following traditional Chinese medicine raw materials in parts by mass: 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 20 parts of glauber salt, 20 parts of amur corktree bark, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 10 parts of liquorice.
3. The traditional Chinese medicine composition for treating cervical-derived vision disorder according to claim 2, wherein the traditional Chinese medicine composition for treating cervical-derived vision disorder is composed of the following traditional Chinese medicine raw materials in parts by mass: 25 parts of astragalus, 20 parts of divaricate saposhnikovia root, 20 parts of cassia twig, 25 parts of kudzuvine root, 25 parts of lycopodium clavatum, 25 parts of red sage root, 25 parts of szechuan lovage rhizome, 25 parts of wild chrysanthemum flower, 25 parts of peppermint, 15 parts of mulberry leaf, 10 parts of ash bark, 25 parts of glauber salt, 20 parts of amur corktree bark, 20 parts of honeysuckle, 25 parts of Chinese angelica, 25 parts of safflower and 10 parts of liquorice.
4. The traditional Chinese medicine composition for treating cervical-derived vision disorder according to claim 1, wherein the traditional Chinese medicine composition for treating cervical-derived vision disorder is composed of the following traditional Chinese medicine raw materials in parts by mass: 20 parts of astragalus, 25 parts of divaricate saposhnikovia root, 25 parts of cassia twig, 20 parts of kudzuvine root, 20 parts of lycopodium clavatum, 20 parts of red sage root, 20 parts of szechuan lovage rhizome, 20 parts of wild chrysanthemum flower, 20 parts of peppermint, 10 parts of mulberry leaf, 15 parts of ash bark, 20 parts of glauber salt, 25 parts of phellodendron, 25 parts of honeysuckle, 20 parts of Chinese angelica, 20 parts of safflower and 15 parts of liquorice.
5. A method for preparing a medicament for treating cervical vision disorder, characterized in that the Chinese medicinal composition for treating cervical vision disorder according to any one of claims 1 to 4 is used, the preparation method comprising the following steps: weighing the raw materials according to the parts by weight, uniformly mixing the raw materials, grinding or decocting the raw materials with water, and preparing into an oral preparation to obtain the medicine for treating cervical dyskinesia.
6. A medicament for the treatment of cervical vision disorders, characterized in that it is prepared by the process for the preparation of a medicament for the treatment of cervical vision disorders according to claim 5.
7. The drug for treating cervical vision disorder according to claim 6, wherein the drug for treating cervical vision disorder is an oral preparation.
8. The drug for treating cervical vision disorder according to claim 7, wherein the oral preparation is any one of decoction, pill, powder, granule, oral liquid, capsule and tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210891726.3A CN115337344B (en) | 2022-07-27 | 2022-07-27 | Traditional Chinese medicine composition and medicine for treating cervical vision disorder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210891726.3A CN115337344B (en) | 2022-07-27 | 2022-07-27 | Traditional Chinese medicine composition and medicine for treating cervical vision disorder and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115337344A CN115337344A (en) | 2022-11-15 |
| CN115337344B true CN115337344B (en) | 2023-07-11 |
Family
ID=83950013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210891726.3A Active CN115337344B (en) | 2022-07-27 | 2022-07-27 | Traditional Chinese medicine composition and medicine for treating cervical vision disorder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115337344B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658640A (en) * | 2009-08-25 | 2010-03-03 | 路正平 | Drug for treating cervical vertigo |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105641401A (en) * | 2016-02-02 | 2016-06-08 | 奎柏（上海）实业有限公司 | Traditional Chinese medicine eye care mask |
| CN110639010A (en) * | 2019-11-15 | 2020-01-03 | 云山化妆品研究开发(广州)有限公司 | Traditional Chinese medicine composition containing recombinant hirudin suitable for eyes and preparation method thereof |
-
2022
- 2022-07-27 CN CN202210891726.3A patent/CN115337344B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658640A (en) * | 2009-08-25 | 2010-03-03 | 路正平 | Drug for treating cervical vertigo |
Non-Patent Citations (1)
| Title |
|---|
| 中药治疗椎动脉型颈椎病用药规律的文献研究;司荣辉等;求医问药(下半月);11(11);135-136 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115337344A (en) | 2022-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
| CN113209208A (en) | Traditional Chinese medicine composition for treating thyroid nodule and preparation method thereof | |
| CN115337344B (en) | Traditional Chinese medicine composition and medicine for treating cervical vision disorder and preparation method thereof | |
| CN105311383A (en) | Healthcare traditional Chinese medicine composition with functions of asthenopia prevention and improvement and preparation method of healthcare traditional Chinese medicine composition with functions of asthenopia prevention and improvement | |
| CN103520649A (en) | Traditional Chinese medicine for treating facial neuritis | |
| CN103933475B (en) | A kind of pharmaceutical composition treating mammary gland fibroma and its production and use | |
| CN104027719B (en) | Traditional Chinese medicine compound composition of hypersplenia liver-depression and spleen-insufficiency type disease caused with treatment infectious endocarditis and preparation method thereof | |
| CN112618660A (en) | Traditional Chinese medicine pearl eye ointment for nourishing blood and improving eyesight and preparation method thereof | |
| CN105194427A (en) | Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese composition | |
| CN105902867B (en) | A herbal composition for reducing hypertension, hyperglycemia and hyperlipidemia, and its preparation method | |
| CN101049371A (en) | Chinese medicament for treating barrenness without sperm, and preparation method | |
| CN101181489A (en) | Chinese medicine composition orally taken for curing glaucoma | |
| CN104147411A (en) | Traditional Chinese medicine preparation for treating primary glaucoma | |
| CN114452365B (en) | Traditional Chinese medicine preparation for treating chalazion | |
| CN104127578B (en) | Traditional Chinese medicine composition for treating acute or chronic rhinitis and preparation method thereof | |
| CN114569643B (en) | Application of carpesium abrotanoides in treating early-stage chalazion | |
| CN105943639A (en) | Traditional Chinese medicine composition assisting in treating chronic subdural hematoma | |
| CN1246358A (en) | Medical capsule for treating cerebroma and its preparing process | |
| CN101116694B (en) | Chinese traditional medicine for treating angitis, method for preparing the same and uses thereof | |
| CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition | |
| CN114732875A (en) | Traditional Chinese medicine formula for treating carotid plaque | |
| CN104524036A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method thereof | |
| CN102068615B (en) | Chinese medicinal liquid for treating sciatica | |
| CN110613784A (en) | Pure natural traditional Chinese medicine prescription for preventing and treating hyperplasia of mammary glands | |
| CN115212266A (en) | Medicine for treating cervical spondylosis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |